187 related articles for article (PubMed ID: 16172969)
21. Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3T.
Sjøbakk TE; Johansen R; Bathen TF; Sonnewald U; Kvistad KA; Lundgren S; Gribbestad IS
BMC Cancer; 2007 Jul; 7():141. PubMed ID: 17662122
[TBL] [Abstract][Full Text] [Related]
22. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
23. Volumetric follow up of brain metastases: a useful method to evaluate treatment outcome and predict survival after Gamma Knife surgery?
Feigl GC; Horstmann GA
J Neurosurg; 2006 Dec; 105 Suppl():91-8. PubMed ID: 18503338
[TBL] [Abstract][Full Text] [Related]
24. The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes.
Gajewicz W; Papierz W; Szymczak W; Goraj B
Med Sci Monit; 2003 Sep; 9(9):MT97-105. PubMed ID: 12960934
[TBL] [Abstract][Full Text] [Related]
25. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
26. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415
[TBL] [Abstract][Full Text] [Related]
27. Boost radiosurgery for treatment of brain metastases after surgical resections.
Iwai Y; Yamanaka K; Yasui T
Surg Neurol; 2008 Feb; 69(2):181-6; discussion 186. PubMed ID: 18261647
[TBL] [Abstract][Full Text] [Related]
28. Frameless image-guided intracranial stereotactic radiosurgery: clinical outcomes for brain metastases.
Breneman JC; Steinmetz R; Smith A; Lamba M; Warnick RE
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):702-6. PubMed ID: 19231101
[TBL] [Abstract][Full Text] [Related]
29. Gamma knife radiosurgery in the management of malignant melanoma brain metastases.
Mathieu D; Kondziolka D; Cooper PB; Flickinger JC; Niranjan A; Agarwala S; Kirkwood J; Lunsford LD
Neurosurgery; 2007 Mar; 60(3):471-81; discussion 481-2. PubMed ID: 17327791
[TBL] [Abstract][Full Text] [Related]
30. Cerebral metastases pathology after radiosurgery: a multicenter study.
Szeifert GT; Atteberry DS; Kondziolka D; Levivier M; Lunsford LD
Cancer; 2006 Jun; 106(12):2672-81. PubMed ID: 16700040
[TBL] [Abstract][Full Text] [Related]
31. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
32. Gamma knife radiosurgery for intracranial haemangioblastomas.
Matsunaga S; Shuto T; Inomori S; Fujino H; Yamamoto I
Acta Neurochir (Wien); 2007 Oct; 149(10):1007-13; discussion 1013. PubMed ID: 17712513
[TBL] [Abstract][Full Text] [Related]
33. Malignant progression of benign brain tumors after gamma knife radiosurgery: is it really caused by irradiation?
Kubo O; Chernov M; Izawa M; Hayashi M; Muragaki Y; Maruyama T; Hori T; Takakura K
Minim Invasive Neurosurg; 2005 Dec; 48(6):334-9. PubMed ID: 16432782
[TBL] [Abstract][Full Text] [Related]
34. Delayed radiation-induced vasculitic leukoencephalopathy.
Rauch PJ; Park HS; Knisely JP; Chiang VL; Vortmeyer AO
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):369-75. PubMed ID: 22024206
[TBL] [Abstract][Full Text] [Related]
35. Gamma knife stereotactic radiosurgery for salivary gland neoplasms with base of skull invasion following neutron radiotherapy.
Douglas JG; Goodkin R; Laramore GE
Head Neck; 2008 Apr; 30(4):492-6. PubMed ID: 18023034
[TBL] [Abstract][Full Text] [Related]
36. Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer.
Lee YK; Park NH; Kim JW; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2008 Mar; 108(3):505-9. PubMed ID: 18191184
[TBL] [Abstract][Full Text] [Related]
37. Clinical impact of magnetic resonance imaging on Gamma Knife surgery for brain metastases.
Perks JR; Liu T; Hall WH; Chen AY
J Neurosurg; 2006 Dec; 105 Suppl():69-74. PubMed ID: 18503333
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of local tumor recurrence from radiation-induced changes after stereotactic radiosurgery for treatment of brain metastasis: case report and review of the literature.
Kickingereder P; Dorn F; Blau T; Schmidt M; Kocher M; Galldiks N; Ruge MI
Radiat Oncol; 2013 Mar; 8():52. PubMed ID: 23497597
[TBL] [Abstract][Full Text] [Related]
39. Long-term survivors after gamma knife radiosurgery for brain metastases.
Kondziolka D; Martin JJ; Flickinger JC; Friedland DM; Brufsky AM; Baar J; Agarwala S; Kirkwood JM; Lunsford LD
Cancer; 2005 Dec; 104(12):2784-91. PubMed ID: 16288488
[TBL] [Abstract][Full Text] [Related]
40. Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases.
Narayana A; Chang J; Yenice K; Chan K; Lymberis S; Brennan C; Gutin PH
Stereotact Funct Neurosurg; 2007; 85(2-3):82-7. PubMed ID: 17167236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
